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Abstract
A 62-year-old female suspected of malignant disease underwent a splenectomy that revealed noncaseating granulomas in the histologi-
cal specimen. Chest X-ray (CXR) and lung CT scans suggested sarcoidosis stage II. TBLB showed noncaseating granulomas. A diagnosis 
of sarcoidosis was made. Initially no treatment was needed as partial remission on CXR and normal lung function were observed. During 
the follow up she underwent open lung biopsy and axillary lymph node biopsy because of radiological progression with presence of 
CXR opacities imitating metastases and recurrent lymphadenopathy. No malignant cells were found. Spontaneous partial resolution of 
disseminated changes on the CXR was observed. Because of progressive deterioration in lung function and the clinical course of the 
disease strongly suggesting the progression of systemic sarcoidosis, the patient was given steroid treatment, which initially resulted in 
partial remission of pulmonary disseminated changes, peripheral lymphadenopathy and improvement in lung function test. Eight months 
later severe deterioration in general condition, anaemia, leukocytosis, hypoxemia, massive hepatomegaly and recurrence of general 
lymphadenopathy along with progression of disseminated changes were found. She died before the final diagnosis was established. 
Post-mortem examination showed a nodal marginal zone B-cell lymphoma with monocytoid B-cells, according to WHO classification. 
The malignant cells were found in the jugular, mediastinal, paratracheal, paragastric, paraintestinal and retroperitoneal lymph nodes and 
they infiltrated the lungs, pleura, liver, thyroid gland and pancreas. No sarcoid granulomas were found in the autopsy.
Key words: sarcoidosis-lymphoma syndrome, sarcoid-like reaction, noncaseating granulomas, diagnostic procedures
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Streszczenie
U 62-letniej kobiety, z klinicznym podejrzeniem choroby rozrostowej układu krwiotwórczego, wykonano splenektomię. W bada-
niu histopatologicznym stwierdzono obecność licznych nieserowaciejących ziarniniaków. Badania obrazowe klatki piersiowej 
pozwoliły na rozpoznanie sarkoidozy płuc w stadium II, którą potwierdzono badaniem histopatologicznym materiału uzyskanego 
drogą przezoskrzelowej biopsji płuca. Chora początkowo nie wymagała leczenia systemowego, ponieważ w trakcie obserwacji 
stwierdzono samoistną częściową regresję zmian rozsianych w płucach. W toku obserwacji, z uwagi na progresję zmian rozsia-
nych w płucach, których morfologia mogła odpowiadać zmianom o charakterze przerzutów oraz z uwagi na powiększenie węzłów 
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obwodowych zweryfikowano rozpoznanie sarkoidozy pobierając wycinki z płuc podczas otwartej biopsji płuca oraz biopsję węzła 
chłonnego pachowego prawego. Nie znaleziono komórek nowotworowych. Ze względu na pogorszenie parametrów wentyla-
cyjnych płuc oraz progresję sarkoidozy płucnej i układowej w toku dalszej obserwacji pacjentkę zakwalifikowano do leczenia 
steroidami systemowymi. Obserwowano poprawę kliniczną, radiologiczną i czynnościową. Po 8 miesiącach leczenia stwierdzono 
nagłe pogorszenie stanu ogólnego, niedokrwistość, leukocytozę, hipoksemię, znaczną hepatomegalię oraz nawrót uogólnionej 
limfadenopatii i zmian rozsianych w płucach. Chora zmarła przed ustaleniem ostatecznego rozpoznania. Na podstawie badania 
autopsyjnego rozpoznano uogólnionego chłoniaka strefy brzeżnej z komórek B, monocytoidalnego. Komórki chłoniaka stwierdzono 
w węzłach chłonnych szyjnych, śródpiersia, rozwidlenia tchawicy, krzywizny większej żołądka, krezki jelita i zaotrzewnowych oraz 
stwierdzono naciekanie narządów wewnętrznych: płuc, opłucnej płucnej, wątroby, tarczycy i trzustki. W badaniu autopsyjnym nie 
stwierdzono obecności ziarniniaków sarkoidalnych w badanych narządach.
Słowa kluczowe: zespół sarkoidoza-chłoniak, odczyn sarkoidalny, nieserowaciejące ziarniniaki, procedury diagnostyczne
Pneumonol. Alergol. Pol. 2013; 81: 542–549 
Introduction
Sarcoidosis is a systemic disease of unknown 
aetiology, with a variable clinical course and mul-
tiple organ involvement. Massive splenomegaly 
with minimal changes in other organs is rare.
The presence of granuloma in a biopsy spe-
cimen is not specific to sarcoidosis. Sarcoid-like 
granulomatous reaction may be present in chronic 
inflammatory, infectious and malignant diseases [1]. 
Sarcoid reaction in the course of neoplastic 
disease can be found in lymph nodes draining 
the area of a tumour, in the tumour itself and in 
non-regional tissues. Overall, sarcoid reaction 
occurs in 4.4% of cancers, 13.8% of patients with 
Hodgkin’s lymphoma (HL) and in 7.3% of cases 
with non Hodgkin’s Lymphoma (NHL) [2]. On 
some occasions sarcoid reactions may be exten-
sive and may cause difficulties in establishing 
diagnosis of an underlying malignant disease [3].
Malignant lympho-proliferative diseases de-
velop at least 5.5 times more often than expected 
in middle-aged patients with chronic active sarco-
idosis, possibly as a consequence of the immuno-
logic abnormalities observed in this disease [4].
In most reported cases of sarcoidosis- 
-lymphoma syndrome, the diagnosis of sarcoido-
sis preceded the diagnosis of lymphoma.
We present a history of a 62-year-old woman 
with sarcoidosis-lymphoma syndrome with fatal 
outcome.
Case report
A 62-year-old female was referred to the Ha-
ematology Department in October 2002 because of 
massive splenomegaly. She had no significant past 
medical or family history. She was asymptomatic. 
On physical examination she was alert with no 
apparent distress. Her spleen was palpable 10 cm 
below the left costal margin and was soft. She had 
no peripheral lymphadenopathy and there was 
no other abnormality on physical examination.
Abnormal laboratory findings included: Ha-
emoglobin (Hb): 9.6 g/L; Haematocrite (Hct) 27.5%, 
low absolute number of leukocytes 2300/mm³ 
(48% of Neutrophils and 29% of Lymphocytes); 
lactate dehydrogenase (LDH): 594 U/L, low total 
protein (5.6 g/dL) with normal serum protein 
electrophoresis. Mild hypercalcaemia was also 
noted (2.7 mmol/L). 
Chest X-ray (CXR) showed a discrete hilar 
and paratracheal lymphadenopathy and bilateral 
disseminated changes. Computed Tomography 
(CT) of the abdomen revealed splenomegaly 
(17 cm × 12 cm), no hepatic changes and mul-
tiple enlarged parapancreatic and retroperitoneal 
lymph nodes (maximal diameter — 15 mm).
In order to exclude possible lymphoma, 
a bone marrow biopsy was performed and showed 
normocellular bone marrow, intact cellular distri-
bution and maturation, 3 lymphoid aggregates, 
increased marrow fibrosis and increased num-
ber of eosinophils. Immunophenotyping of cells 
demonstrated CD5(+) — 71%, CD19(+) — 3%, 
CD20(+) — 12%, CD20(+)10(+) — 2%, CD10(+) 
— 4%, CD34(+) — 7%, CD34(+)33(+) — 5% and 
CD33(+) — 16%. 
The conclusions were normal lymphocytes T 
CD5(+) count, normal lymphocyte B count; myelo-
id line stem cells CD34(+)/CD33(+) were present. 
The patient underwent splenectomy becau-
se of progressive enlargement of the organ. The 
histopathological examination revealed small, 
sarcoid-like epithelioid granulomas with giant 
cells and no necrosis, with fibrosis (Fig. 1). The 
initial diagnosis was systemic sarcoidosis, and the 
patient was referred to the Pulmonary Department 
in June 2003. Her general condition was very 
good, with no complaints. CXR revealed bilateral 
hilar lymphadenopathy and disseminated chan-
ges with partial resolution, when compared to 
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CXR from the Haematology Department (Fig. 2). 
Thoracic CT revealed numerous enlarged media-
stinal and pulmonary lymph nodes associated 
with disseminated changes typical for sarcoido-
sis. No anaemia or leukopenia were observed. 
Blood biochemical parameters were within nor-
mal limits, including liver function tests, total 
protein level and serum protein electrophoresis. 
The serum activity of angiotensin-converting 
enzyme (ACE) was elevated (113 U/L, normal 
value 8–52 U/L).
Contrast enhanced abdominal CT after sple-
nectomy showed partial remission of the abdo-
minal lymphadenopathy. On bronchoscopy, no 
macroscopic abnormalities were detected. Trans-
bronchial lung biopsies (TBLB) contained mul-
tiple noncaseating, epithelioid cell granulomata, 
without signs of malignant disease. Cultures and 
staining for acid fast bacilli (AFB) and fungi were 
negative. Lung function testing (LFT) revealed 
a mild decrease in static lung compliance (Cst 
=1.59 L/kPa, 65% of predicted value), with no 
impairment of other parameters.
A diagnosis of systemic sarcoidosis involving 
the lungs, lymph nodes and spleen was confir-
med. Because of her good general condition, no 
complaints, almost normal LFT and partial resolu-
tion of disseminated changes in chest CT scan, the 
patient did not receive any systemic treatment.
She was readmitted to the Pulmonary De-
partment two months later (August 2003) be-
cause of fever, sweats and weight loss associated 
with non-productive cough. She appeared quite 
well on physical examination and no rash or 
lymphadenopathy were noted. Late inspiratory 
crackles were heard at both lung bases. The liver 
was not palpable. Blood analysis showed mild 
anaemia (Hb 11.5 g/dL, Hct 38.1%, RBC 4.57), 
mild leukocytosis (WBC 12 100/mm³), normal 
smear and a slight impairment of liver function 
tests (aspartate aminotransferase AST 52 U/L; 
alanine aminotransferase ALT 73 U/L; alkaline 
phosphatase ALP 337 U/L) with normal bilirubin 
concentration and negative serology for hepatitis. 
Chest CT scan showed extensive dissemina-
ted ground–glass opacities with mild mediastinal 
and hilar lymphadenopathy (Fig. 3). The abdo-
minal CT scan showed enlarged lymph nodes in 
Figure 1. Granulomas of spleen. Small, sarcoid-like epithelioid granulo-
mas with giant cells and no necrosis, with fibrosis. Microphotograph. 
H+E stain, low magnification
Figure 2. Chest X-ray: diffuse reticular and nodular opacities predomi-
nantly in the middle lung zones. Slightly enlarged hilar and mediastinal 
lymph nodes. Widening of the upper mediastinum on the right mostly 
due to prominent superior vena cava. No significant changes in com-
parison with previous radiograph from April 2003 were shown
Figure 3. HRCT; multiple, various sized nodules in both lungs predomi-
nantly in the lower lung zones
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the left para-aortic region and left renal hilum 
(18 mm). No other abnormalities were found. 
Bronchoscopy did not reveal any abnormalities. 
Chest CT scan findings were not consistent 
with sarcoidosis. She underwent an open lung 
biopsy in order to exclude any neoplastic dise-
ase. The histopathological examination of biopsy 
specimens revealed three types of abnormalities: 
multiple, well-formed granulomas consisting 
predominantly of epithelioid cells, giant cells 
with a peripheral rim of inflammatory cells and 
fibrosis, organizing pneumonia pattern with 
polypoid plugs of loose connective tissue filling 
airspaces, and intra-alveolar organizing exudates 
forming small granuloma-like patterns (Figs 4–6).
One month later (September 2003), seen at 
the outpatient clinic, the patient reported a si-
gnificant improvement in general condition. She 
only complained of painful hands and joints, 
palm X-ray revealed no abnormalities. The only 
abnormality found on physical examination was 
an enlarged (1.5 cm diameter) right supraclavicu-
lar lymph node. Because of suspicion of systemic 
disease, she was screened for serological markers 
in order to exclude connective tissue disease. No 
rheumatoid factor or antinuclear antibodies could 
be demonstrated. Neurological and dermatologi-
cal examination revealed no abnormalities. 
CXR and CT scans revealed partial sponta-
neous resolution of diffuse nodular opacities.
Regarding the multiple specimen examina-
tion (spleen, TBLB, open lung biopsy specimens) 
consistent with sarcoidosis, the clinical outcome 
and spontaneous regression of lung and abdomi-
nal pathology in the radiological examinations, 
the diagnosis of sarcoidosis was re-confirmed.
The patient was admitted again to the Pulmo-
nology Department in January 2004 with fever, 
weight loss and sweats. The physical examination 
revealed generalized peripheral lymphadenopa-
thy (supraclavicular, jugular, axillar, inguinal). 
Peripheral blood counts showed microcytic ana-
emia (Hb 11,1 g/dL, Hct 34%; Mean Corpuscular 
Volume MCV 78 fl, Mean Corpuscular Haemoglo-
bin Concentration MCH 25.5 pg), normal WBC 
(8.6/mm³) with 52% of Neutrophils and 25% of 
Lymphocytes. The erythrocyte sedimentation rate 
(ESR) was modestly elevated — 35/hour. Serum 
ACE activity level was elevated (143 U/L). Low 
total protein count (5.6 g/dL) was found, with 
normal serum protein electrophoresis. Other 
Figure 4. Open surgical wedge biopsy of lung. Multiple, well-formed 
granulomas consist of predominantly epithelioid cells, giant cells with 
peripheral rim of inflammatory cells and fibrosis. Microphotograph. 
H+E stain, high magnification
Figure 5. Open surgical wedge biopsy of lung. Organizing pneumonia 
pattern with polypoid plugs of loose connective tissue filling airspaces. 
Mildly thickened alveolar septa with mild lymphocytic infiltrate. The 
architecture of the lung is preserved. Microphotograph. H+E stain, 
low magnification
Figure 6. Open surgical wedge biopsy of lung. Intra-alveolar organizing 
exudates forming small granuloma-like pattern. Granuloma consists 
of epithelioid cells and lymphocytic infiltrate. Microphotograph. H+E 
stain, high magnification
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parameters were within normal limits (including 
liver function tests and serum calcium level).
A biopsy specimen of a right axillary lymph 
node revealed only reactive inflammatory chan-
ges. The immunohistochemistry for CD20, CD3, 
CD30 and CD15 were negative. 
CXR showed progression of disseminated 
changes. Skin test with purified protein derivative 
tuberculin test (PPD tuberculin test) was negative. 
On the third bronchoscopy no abnormalities were 
detected macroscopically. The biopsy specimen 
was reported as consistent with sarcoidosis. 
Examination of the bronchoalveolar fluid sho-
wed 57% macrophages, 39% lymphocytes and 
3% neutrophils. The T cell helper-suppressor 
ratio was 3: 1. Cultures and staining techniques 
for fungal, mycobacterial disease or AFB were 
negative. Lung function testing revealed a mar-
ked decrease in the diffusion capacity for carbon 
monoxide (DLCO 39% pred). The diagnosis of 
sarcoidosis was confirmed, based on compatible 
clinical and radiological features and histologi-
cal demonstration of non-caseating granulomas. 
Progressive deterioration in lung function and the 
clinical course of the disease strongly suggested 
the progression of systemic sarcoidosis. She was 
given steroids, starting from a dose of 30 mg/ 
/day of prednisone for one month, followed by 6 
months of gradually tapering the dose to 10 mg/d. 
Corticotherapy resulted in partial resolution of 
pulmonary disseminated changes, total resolution 
of peripheral lymphadenopathy but no improve-
ment in LFT. 
Eight months later she was readmitted due 
to severe deterioration of health status, anaemia 
(Hb 10.9 g/dL; E 4.65/mm³), leukocytosis (20/ 
/mm³), hypoxemia (partial arterial oxygen pressu-
re PaO2 47 mm Hg, partial arterial carbon dioxide 
pressure PaCO2 31 mm Hg, pH 7.38), massive 
hepatomegaly, general lymphadenopathy and 
progression of disseminated changes on CXR. 
Contrast enhanced abdominal CT was performed 
before the patient was readmitted to the Pulmo-
nary Department and showed multiple enlarged 
parapancreatic, retroperitoneal and paravertebral 
lymph nodes, a focal lesion (25 mm in diameter) 
in the right lobe of the liver — haemangioma and 
perihepatic fluid collection (Fig. 7). The patient 
died due to respiratory distress before the final 
diagnosis was made. The post-mortem examina-
tion showed nodal marginal zone B-cell lympho-
ma with monocytoid B-cells, according to WHO 
classification. The malignant cells were found in 
the jugular, mediastinal, paratracheal, paragastric, 
paraintestinal and retroperitoneal lymph nodes 
and they infiltrated the lungs, pleura, liver, thy-
roid gland and pancreas. No sarcoid granulomas 
were found in the autopsy (Figs 8, 9).
Discussion
The presented case should be discussed from 
three points of view: 
—  sarcoidosis-lymphoma syndrome,
—  the clinical picture of sarcoidosis, that is 
associated with malignant disease,
—  the risk and incidence of malignant disease 
in sarcoid patients.
Figure 7. Contrast enhanced abdominal CT. Multiple enlarged parapan-
creatic, retroperitoneal and paravertebral lymph nodes. Focal lesion 
(25 mm in diameter) in the right lobe of the liver – haemangioma. 
Perihepatic fluid collection
Figure 8. Lymph node involvement by diffuse infiltrate of B-cell lym-
phoma. Tumour cells are strong positive for CD20. Microphotograph 
of lymph node. H+E stain and immunostain CD20 (inset), low ma-
gnification
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According to Papanikolaou and Sharma, 
the diagnostic criteria of sarcoidosis-lymphoma 
syndrome are biopsy-proven sarcoidosis, based 
on American Thoracic Society/European Respi-
ratory Society/World Association of Sarcoidosis 
and Other Granulomatous Diseases (ATS/ERS/ 
/WASOG) criteria coexisting with biopsy-proven 
lymphoma according to WHO classification, with 
the exclusion of local sarcoid reaction [5]. Those 
entities may occur simultaneously, but in most 
described cases sarcoidosis precedes lymphoma.
Sarcoidosis and lymphoma may share clini-
cal, laboratory and histological findings, as was 
seen in the presented female.
The abnormality that led our patient to 
seek medical advice was massive splenomegaly, 
with mild leukocytopenia and anaemia. She was 
screened for lymphoproliferative disease with 
different biopsy specimen verification; none 
confirmed the malignancy. 
Splenomegaly may be found in both clinical 
situations: sarcoidosis and sarcoidosis-lympho-
ma syndrome. Spleen enlargement is observed 
in 1–40% of sarcoid patients, depending on the 
method of diagnosis (physical examination, 
radiography) and some patients with massive 
splenomegaly are managed with splenectomy 
[6, 7], as was done in our case.
Splenomegaly is associated with clinical evi-
dence of more extensive extrathoracic sarcoidosis 
and a poor prognosis [8]. 
In our patient anaemia and leukopenia were 
observed at the initial evaluation at the Haema-
tological Department. These abnormalities were 
probably due to splenomegaly with related hy-
persplenism because the morphology parameters 
normalized after splenectomy. Hypercalcaemia 
was also observed in the initial course of disease. 
Hypercalcaemia in sarcoidosis is a result of the 
large burden of macrophages in splenic granu-
lomas that contain hydroxylase, which converts 
vitamin D to its active form [9].
Hypercalcaemia and increased serum activity 
of angiotensin converting enzyme are common 
findings in active and often progressive forms of 
sarcoidosis but have been also described in pa-
tients with isolated lymphoma [10]. The elevated 
ACE levels were indicated by Papanikolaou and 
Sharma as a significantly differentiating feature in 
sarcoidosis-lymphoma syndrome with lymphoma 
as a second disease to sarcoidosis [5].
The diagnosis of sarcoidosis in our patient, 
a 62-year-old female, was consistent with cases 
of splenic sarcoidosis reported in the literature 
[6, 11–13]. In the described cases, sarcoidosis 
was diagnosed in middle-aged women, with sple-
nomegaly, small mediastinal lymph nodes and 
some non-specific parenchymatous pulmonary 
nodules. The diagnosis of sarcoidosis was made 
on the basis of splenectomy after eliminating 
other causes of granulomatosis. Only in one of the 
described cases the diagnosis of sarcoidosis pre-
ceded that of Hodgkin’s disease (HD) by 29 years 
[13]. Massive splenomegaly had been present 
for 13 years before HD was diagnosed following 
splenectomy. In other cited cases no malignant 
diseases following splenectomy in sarcoid pa-
tients were reported [6, 8, 9]. In the Papanikolaou 
and Sharma review of cases of patients in which 
sarcoidosis and lymphoma were diagnosed in 
the same patient, one of the cardinal feature of 
lymphoma, when presented as a second disease, 
was splenomegaly [5].
The authors underlined the necessity of an 
extensive investigation of the cause of splenic 
granulomatosis as the diagnosis of sarcoidosis re-
mains one of elimination. Massive splenomegaly 
is rare in sarcoidosis and warrants exclusion of 
the malignancy [14].
According to Papanikolaou and Sharma, the 
development of new lymph node disease and 
splenic involvement in the course of chronic 
sarcoidosis should be investigated promptly in 
order to rule out concomitant lymphoma. These 
findings correlated with the predominance of 
non-Hodgkin lymphoma (NHL) in selected cases 
[5, 15]. Our patient underwent multiple invasive 
diagnostic procedures (splenectomy, open lung 
biopsy, lymph nodes biopsy, transbronchial 
lung biopsy) to exclude any possible malignant 
concomitant condition, but all of the obtained 
specimens revealed sarcoid-like granulomas.
Figure 9. Lung and liver with diffuse infiltrate of large B-cell lympho-
ma. Microphotograph. H+E stain, low magnification
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Sarcoidosis preceding lymphoma manifests 
with bilateral hilar lymphadenopathy and pa-
renchymal disease [5, 16–18]. Such radiological 
pathology was found when the patient presented 
for the initial evaluation at the Haematological 
Department.
Non-caseating epithelioid granulomas may 
be found as sarcoid-like reactions in different 
organs. These reactions, secondary to malignan-
cies, are thought to occur either adjacent to the 
primary malignant site or to local drainage no-
des. Our patient was diagnosed with sarcoidosis 
based on ATS/ERS/WASOG criteria [19] with no 
evidence of coexisting malignant disease, so local 
sarcoid-like reaction was excluded. 
In Brincker’s review of 46 cases of coexistent 
sarcoidosis and malignant lymphoproliferative 
disease [4] three characteristic features appeared: 
the lymphoma was preceded by sarcoidosis, pa-
tients were elderly when developing sarcoidosis 
and sarcoidosis-associated lymphoma was more 
frequently Hodgkin’s disease than was expected.
Our patient fulfilled the criteria of sarco-
idosis-lymphoma syndrome. The presented case 
was consistent with two out of three Brincker’s 
characteristics. 
The time interval from onset of sarcoidosis 
to the development of lymphoma in our case was 
23 months. In the literature the time interval from 
the onset of sarcoidosis to the development of 
lymphoma varies from months to years [12, 20]. 
It is estimated that the mean interval between 
the diagnosis of sarcoidosis and lymphoma is 24 
months [21].
Our patient was 62 years old when she 
developed sarcoidosis, and 2 years later B cell 
lymphoma was diagnosed. According to the li-
terature, lymphoproliferative disease is 5 times 
more frequent in middle-aged persons who have 
chronic active sarcoidosis than in the remaining 
patients. In half of them low-grade lymphomas 
develop [21].
In Brincker’s series the most common lym-
phoma associated with sarcoidosis was HD [4]. 
Karakantza et al. confirmed the association be-
tween sarcoidosis and lymphoma, but they conc-
luded that all types of lymphoma may develop 
[20]. In their study 2 out of 5 patients were dia-
gnosed with B cell lymphoma, as was the case in 
our patient.
Impairment of the immune system in the 
form of an altered cell reaction leads to increased 
T-helper cell accumulation in the sarcoid tissues 
and secondary reduction of the circulating po-
pulation of these cells. This may implicate the 
greater susceptibility to oncogenic viruses [22] 
and may partially explain the higher incidence 
of malignant disease in sarcoid patients.
According to Brincker’s suggestions, the 
chronic form of sarcoidosis and treatment with 
steroids are predisposing factors for lymphoma 
development [4].
In our patient the histopathological examina-
tion of biopsy specimen of the spleen, open lung 
biopsy and TBLB were consistent with sarcoidosis, 
and the clinical course, with partial spontaneous 
resolution of pulmonary infiltrates, initial impro-
vement in general condition of the patient and 
lack of malignant cells in lymph nodes and trepan 
biopsy, strongly supported the initial diagnosis of 
chronic sarcoidosis. Subsequently our patient de-
veloped multi-organ sarcoidosis with progressive 
pulmonary involvement on CTX and deterioration 
of LFT that needed systemic steroid treatment. 
The time interval between the diagnosis of 
lymphoma and the last biopsy specimen verifica-
tion of sarcoidosis, in our patient, was 8 months. 
Reich hypothesizes that clinical sarcoidosis is 
a generalized cell-mediated immune response 
to tumour antigens [23]. This may explain why 
malignant disease is diagnosed in most cases 
shortly after the onset of sarcoidosis. 
Although in most described cases the dia-
gnosis of sarcoidosis preceded the appearance 
of lymphoma, the time relationship between 
sarcoidosis and lymphoma is variable [16–18]. 
A case of a middle-aged women with massive 
splenomegaly, bone marrow involvement by 
lymphoma and granulomas which responded to 
chemotherapy was described [24]. Recently it 
has been confirmed that in the majority of sarco-
idosis-lymphoma cases, sarcoidosis precedes the 
lymphoma, and the NHL types of lymphoma are 
most commonly found [5].
Our case is consistent with this observation. 
The increased risk of malignancy in patients 
with sarcoidosis has been examined in several 
studies. Swedish authors found that among ho-
spitalized patients in Sweden the risk of NHL 
was significantly increased, and this was related 
to deregulated immune function [25]. The same 
authors observed that old age at hospitalization 
was associated with a high risk of developing 
cancer in sarcoid patients, which was confirmed 
in our patient. This indicates the need for special 
clinical attention in elderly patients with diagno-
sis of sarcoidosis.
Because of the similarities in the clinical co-
urse, radiological picture and laboratory findings 
between sarcoidosis and lymphoma, it is possible 
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that at the initial diagnosis of sarcoidosis clini-
cians may not recognize the coexistence of lym-
phoma. Thus, without multiple biopsy specimens 
the distinction between benign and malignant di-
sorders, even on the basis of sophisticated modern 
techniques, is not possible. In rare cases (like the 
one presented) extensive diagnostic procedures 
are not helpful in establishing final diagnosis.
In such clinical situations careful follow up 
of the patient is advised. 
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